BioNexus Gene Lab - 5 Year Stock Price History | BGLC
Historical daily share price chart and data for BioNexus Gene Lab since 2020 adjusted for splits and dividends. The latest closing stock price for BioNexus Gene Lab as of November 13, 2025 is 4.52.
- The all-time high BioNexus Gene Lab stock closing price was 285.60 on March 03, 2021.
- The BioNexus Gene Lab 52-week high stock price is 15.60, which is 245.1% above the current share price.
- The BioNexus Gene Lab 52-week low stock price is 2.01, which is 55.5% below the current share price.
- The average BioNexus Gene Lab stock price for the last 52 weeks is 4.01.
| BioNexus Gene Lab Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 4.1885 | 3.9900 | 11.1400 | 2.1700 | 4.5200 | 61.43% |
| 2024 | 4.9680 | 5.2200 | 15.7000 | 2.2900 | 2.8000 | -47.17% |
| 2023 | 42.5774 | 120.0000 | 144.0000 | 3.3000 | 5.3000 | -95.35% |
| 2022 | 161.2843 | 240.0000 | 267.6000 | 86.4000 | 114.0000 | -55.40% |
| 2021 | 207.8730 | 0.0023 | 285.6000 | 0.0017 | 255.6000 | 11112943.48% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.008B | $0.010B |
| BioNexus Gene Lab Corp. is an emerging company in the business of selling chemical raw materials principally in the Southeast Asia region and the development of biopsy tests for early diagnosis and personalized health management. BioNexus Gene Lab Corp. is based in KUALA LUMPUR, Malaysia. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $156.245B | 28.69 |
| HCA Healthcare (HCA) | United States | $108.000B | 17.88 |
| CVS Health (CVS) | United States | $100.590B | 11.57 |
| Elevance Health (ELV) | United States | $72.957B | 10.70 |
| Cencora (COR) | United States | $70.853B | 22.85 |
| Natera (NTRA) | United States | $27.695B | 0.00 |
| DiDi Global (DIDIY) | China | $25.933B | 21.19 |
| Labcorp Holdings (LH) | United States | $22.206B | 16.93 |
| Medpace Holdings (MEDP) | United States | $16.656B | 41.35 |
| BioMerieux (BMXMF) | France | $15.266B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.321B | 0.00 |
| ICON (ICLR) | Ireland | $13.200B | 13.10 |
| Solventum (SOLV) | United States | $13.047B | 12.66 |
| Viatris (VTRS) | United States | $12.566B | 4.68 |
| CochLear (CHEOY) | Australia | $11.666B | 0.00 |
| Revvity (RVTY) | United States | $10.589B | 19.50 |
| HealthEquity (HQY) | United States | $8.573B | 34.31 |
| Charles River Laboratories (CRL) | United States | $8.328B | 16.04 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.856B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $6.816B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $5.726B | 34.14 |
| Bausch + Lomb (BLCO) | Canada | $5.557B | 36.49 |
| Sotera Health (SHC) | United States | $4.548B | 21.93 |
| Amplifon S.p.A (AMFPF) | Italy | $4.059B | 23.68 |
| GeneDx Holdings (WGS) | United States | $3.768B | 66.17 |
| Alignment Healthcare (ALHC) | United States | $3.356B | 0.00 |
| Concentras Parent (CON) | United States | $2.531B | 15.80 |
| Premier (PINC) | United States | $2.325B | 22.53 |
| Progyny (PGNY) | United States | $2.105B | 41.39 |
| Organon (OGN) | United States | $1.981B | 2.09 |
| Surgery Partners (SGRY) | United States | $1.980B | 25.52 |
| Pediatrix Medical (MD) | United States | $1.943B | 11.60 |
| Establishment Labs Holdings (ESTA) | $1.882B | 0.00 | |
| PACS (PACS) | United States | $1.631B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.255B | 0.00 |
| Omada Health (OMDA) | $1.203B | 0.00 | |
| GoodRx Holdings (GDRX) | United States | $1.042B | 17.06 |
| Embecta (EMBC) | United States | $0.843B | 4.93 |
| CareDx (CDNA) | United States | $0.816B | 13.34 |
| InnovAge Holding (INNV) | United States | $0.727B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.617B | 8.50 |
| Nutex Health (NUTX) | United States | $0.604B | 9.15 |
| Sonida Senior Living (SNDA) | United States | $0.601B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.508B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| CryoPort (CYRX) | United States | $0.439B | 0.00 |
| Enhabit (EHAB) | United States | $0.412B | 18.52 |
| Strata Critical Medical (SRTA) | United States | $0.399B | 0.00 |
| So-Young (SY) | China | $0.365B | 0.00 |
| Pomdoctor - (POM) | China | $0.362B | 0.00 |
| SBC Medicals (SBC) | United States | $0.349B | 7.64 |
| Shoulder Innovations (SI) | United States | $0.303B | 0.00 |
| Oncology Institute (TOI) | United States | $0.288B | 0.00 |
| KindlyMD (NAKA) | United States | $0.275B | 0.00 |
| Agilon Health (AGL) | United States | $0.250B | 0.00 |
| LifeMD (LFMD) | United States | $0.219B | 0.00 |
| Beauty Health (SKIN) | United States | $0.166B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.157B | 26.99 |
| Ascend Wellness Holdings (AAWH) | United States | $0.129B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.111B | 0.00 |
| DocGo (DCGO) | United States | $0.102B | 0.00 |
| Biodesix (BDSX) | United States | $0.063B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.049B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.034B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.023B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.023B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.019B | 6.84 |
| SeaStar Medical Holding (ICU) | United States | $0.016B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.012B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| ISpecimen (ISPC) | United States | $0.006B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |